IHE - 5 Biggest Pharmaceutical ETFs in 2024

2024-05-29 16:15:00 ET

The pharmaceutical market reached a total value of US$1.6 trillion in 2023, according to Statista , up significantly from US$888 billion in 2010.

Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma companies. Like all ETFs, a pharmaceutical ETF is a good option for those who want to trade a set of assets in the pharmaceutical industry instead of focusing solely on individual pharmaceutical stocks.

The main advantage of a pharma ETF is the fact that it can provide exposure to an overarching sector, but still trades like a stock. Pharma ETFs also offer less market volatility and lower fees and expenses.

For further details see: